Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
Recent Posts
- NJACTS Community Engagement Core COVID-19 Resources
- Adverse Childhood Experiences Influence Potentially Dangerous Firearm-Related Behavior in Adulthood.
- NJ joins lawsuit against Trump over cuts to medical research that would hit Rutgers.
- Simulation Training: A Powerful Tool to Bridge Theory and Practice.
- New NJACTS Publication
Categories
- Community (2,139)
- Covid (982)
- CTO Events (6)
- News (2,729)
- Pilots (21)